Whitney Hanken
Acute Care · Cedar Rapids, IANPI 1366963233
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $64,493 of the $73,366 with a category attached, or 87.9%. AbbVie accounts for 66.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $40,415 and has fallen 99.3% since, to $293 in 2025. Among acute care clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $400.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$49K
- Biohaven Pharmaceuticals, Inc.$21K
- Biohaven Pharmaceutical Holding Company Ltd.$4K
- Merck$68
- Vertex$61
- Avanos Medical$22
- plus $72 from 4 others
What the payments were for
- Speaking & faculty fees$64,49388%
- Travel & lodging$5,7818%
- Food & beverage$3,0924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 111 | $48,540 |
| Biohaven Pharmaceuticals, Inc. | 46 | $20,591 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $4,014 |
| Merck | 3 | $68 |
| Vertex | 2 | $61 |
| Avanos Medical | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Incyte Corporation | 1 | $18 |
| Medtronic | 1 | $17 |
| AstraZeneca | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$40,535
- NURTEC ODT$23,533
- QULIPTA$7,056
How this compares
$73,366 in reported general payments places this provider in the 95th percentile of 104 acute care providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 43 | $441 |
| Baclofen | 11 | $87 |
| Tramadol Hcl | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other acute care in Cedar Rapids
- Nicole BanasikCedar Rapids$4K
- Shelly McGurkCedar Rapids$2K
- Alison GillisCedar Rapids$2K
- Tiffany EhlersCedar Rapids$1K
- Carrie CampbellCedar Rapids$1K
- Sarah KasprykCedar Rapids$895
- Sara HubbellCedar Rapids$732
- Kiley SchroederCedar Rapids$631
- Lisa MahoneyCedar Rapids$396
- Michele TangemanCedar Rapids$339
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.